167 related articles for article (PubMed ID: 36471936)
1. [Biomarkers related to cognitive dysfunction in APP/PS1 mice based on non-targeted metabonomics and intervention mechanism of Huanglian Jiedu Decoction].
Wang LN; Gu XR; Si N; Wang HJ; Zhou YY; Bian BL; Zhao HY
Zhongguo Zhong Yao Za Zhi; 2022 Nov; 47(22):6117-6126. PubMed ID: 36471936
[TBL] [Abstract][Full Text] [Related]
2. Untargeted metabolomics and lipidomics uncovering the cardioprotective effects of Huanglian Jiedu Decoction on pathological cardiac hypertrophy and remodeling.
Chen QQ; Wang FX; Cai YY; Zhang YK; Fang JK; Qi LW; Zhang L; Huang FQ
J Ethnopharmacol; 2021 Apr; 270():113646. PubMed ID: 33264659
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of Huanglian Jiedu decoction in treating Alzheimer's disease by regulating microbiome
Zheng R; Shi S; Zhang Q; Yuan S; Guo T; Guo J; Jiang P
Front Cell Infect Microbiol; 2023; 13():1140945. PubMed ID: 37009506
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics-based mechanisms exploration of Huang-Lian Jie-Du decoction on cerebral ischemia via UPLC-Q-TOF/MS analysis on rat serum.
Zhu B; Cao H; Sun L; Li B; Guo L; Duan J; Zhu H; Zhang Q
J Ethnopharmacol; 2018 Apr; 216():147-156. PubMed ID: 29360497
[TBL] [Abstract][Full Text] [Related]
5. Huanglian Jiedu decoction remodels the periphery microenvironment to inhibit Alzheimer's disease progression based on the "brain-gut" axis through multiple integrated omics.
Gu X; Zhou J; Zhou Y; Wang H; Si N; Ren W; Zhao W; Fan X; Gao W; Wei X; Yang J; Bian B; Zhao H
Alzheimers Res Ther; 2021 Feb; 13(1):44. PubMed ID: 33579351
[TBL] [Abstract][Full Text] [Related]
6. Involvement of Huanglian Jiedu Decoction on Microglia with Abnormal Sphingolipid Metabolism in Alzheimer's Disease.
Qi YY; Heng X; Yao ZY; Qu SY; Ge PY; Zhao X; Ni SJ; Guo R; Yang NY; Zhang QC; Zhu HX
Drug Des Devel Ther; 2022; 16():931-950. PubMed ID: 35391788
[TBL] [Abstract][Full Text] [Related]
7. [Effects of Chinese herbal medicine Huanglian Jiedu Decoction on urine metabonomics of healthy people].
Liu SM; Li JH; Liu CF; Cao M; Wang N
Zhong Xi Yi Jie He Xue Bao; 2011 Jan; 9(1):77-83. PubMed ID: 21227037
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacodynamics of Huanglian Jiedu decoction in Alzheimer's disease (AD) model rats and effect on improvement of inflammation microenvironment in brain].
Gu XR; Fang SY; Ren W; Wang HJ; Yang J; Si N; Bian BL; Zhao HY
Zhongguo Zhong Yao Za Zhi; 2018 Jul; 43(14):3006-3011. PubMed ID: 30111062
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of Huang-lian-Jie-du decoction and its effective fraction in alleviating acute ulcerative colitis in mice: Regulating arachidonic acid metabolism and glycerophospholipid metabolism.
Yuan Z; Yang L; Zhang X; Ji P; Hua Y; Wei Y
J Ethnopharmacol; 2020 Sep; 259():112872. PubMed ID: 32417423
[TBL] [Abstract][Full Text] [Related]
10. A Urinary Metabolomics Analysis Based on UPLC-MS and Effects of Moxibustion in APP/PS1 Mice.
He R; Liu J; Huang C; Liu J; Cui H; Zhao B
Curr Alzheimer Res; 2020; 17(8):753-765. PubMed ID: 33167836
[TBL] [Abstract][Full Text] [Related]
11. Huanglian Jiedu Decoction in the Treatment of the Traditional Chinese Medicine Syndrome "Shanghuo"-An Intervention Study.
Luo K; Zhao H; Bian B; Wei X; Si N; Brantner A; Fan X; Gu X; Zhou Y; Wang H
Front Pharmacol; 2021; 12():616318. PubMed ID: 33995016
[TBL] [Abstract][Full Text] [Related]
12. Explore of the beneficial effects of Huang-Lian-Jie-Du Decoction on diabetic encephalopathy in db/db mice by UPLC-Q-Orbitrap HRMS/MS based untargeted metabolomics analysis.
He WJ; Cao DM; Chen YB; Shi JJ; Hu T; Zhang ZT; Lan T; Tang D; Wang SM
J Pharm Biomed Anal; 2021 Jan; 192():113652. PubMed ID: 33039912
[TBL] [Abstract][Full Text] [Related]
13. Urine and plasma metabonomics coupled with UHPLC-QTOF/MS and multivariate data analysis on potential biomarkers in anemia and hematinic effects of herb pair Gui-Hong.
Li S; Lin H; Qu C; Tang Y; Shen J; Li W; Yue S; Kai J; Shang G; Zhu Z; Zhang C; Liu P; Yan H; Zhang L; Qian L; Qian D; Duan JA
J Ethnopharmacol; 2015 Jul; 170():175-83. PubMed ID: 25985767
[TBL] [Abstract][Full Text] [Related]
14. Study on the Molecular Basis of Huanglian Jiedu Decoction Against Atopic Dermatitis Integrating Chemistry, Biochemistry, and Metabolomics Strategies.
Chen J; Chen S; Chen J; Shen B; Jiang Z; Xu Y
Front Pharmacol; 2021; 12():770524. PubMed ID: 34970141
[TBL] [Abstract][Full Text] [Related]
15. [Experimental study on improvement of cognitive impairment in Alzheimer's disease by different degrees of steaming and sunning of Polygoni Multiflori Radix based on fecal metabolomics].
Zhou GL; Li SY; Luo X; Chen H; Chi XY; Liu SL; Yang K; Zeng CH
Zhongguo Zhong Yao Za Zhi; 2024 Apr; 49(8):2147-2157. PubMed ID: 38812230
[TBL] [Abstract][Full Text] [Related]
16. Systems pharmacology, proteomics and in vivo studies identification of mechanisms of cerebral ischemia injury amelioration by Huanglian Jiedu Decoction.
Shang J; Li Q; Jiang T; Bi L; Lu Y; Jiao J; Song Q; Yan M; Shabuerjiang L; Wang J; Liu X
J Ethnopharmacol; 2022 Jul; 293():115244. PubMed ID: 35378193
[TBL] [Abstract][Full Text] [Related]
17. Integrating network pharmacology and non-targeted metabolomics to explore the common mechanism of Coptis Categorized Formula improving T2DM zebrafish.
He T; Wang M; Kong J; Wang Q; Tian Y; Li C; Wang Q; Liu C; Huang J
J Ethnopharmacol; 2022 Feb; 284():114784. PubMed ID: 34718103
[TBL] [Abstract][Full Text] [Related]
18. High-Throughput Metabolomics for Discovering Potential Metabolite Biomarkers and Metabolic Mechanism from the APPswe/PS1dE9 Transgenic Model of Alzheimer's Disease.
Yu J; Kong L; Zhang A; Han Y; Liu Z; Sun H; Liu L; Wang X
J Proteome Res; 2017 Sep; 16(9):3219-3228. PubMed ID: 28753016
[TBL] [Abstract][Full Text] [Related]
19. [Metabolomic study on urine of chronic inflammation rats treated with Buyang Huanwu Decoction based on UPLC-Q-TOF-MS].
You XY; Jiang L; Wang WF; Xu X; Zhang SW; Liu HN; Yan XJ; Nie P; Li BT; Xu GL
Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(19):5345-5355. PubMed ID: 38114124
[TBL] [Abstract][Full Text] [Related]
20. [Study on biomarkers of acteoside in treating puromycin aminonucleoside nephropathy in young rats based on non-targeted urine metabolomics technology].
Wang MX; Luo KK; Gao WY; Tian MY; Zhao HY; Si N; Bian BL; Wei XL; Wang HJ; Zhou YY
Zhongguo Zhong Yao Za Zhi; 2023 Nov; 48(21):5898-5907. PubMed ID: 38114186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
